BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1017582)

  • 1. Antibody-dependent macrophage-mediated cytolysis in a murine syngeneic tumor system.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1976 Oct; 67(5):651-60. PubMed ID: 1017582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
    Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
    Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of macrophage-mediated cytolysis by lipoproteins from cell-free tumorous ascites.
    Yamazaki M; Shinoda H; Hattori R; Mizuno D
    Gan; 1977 Aug; 68(4):513-6. PubMed ID: 211066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
    Haskill JS; Fett JW
    J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cytolysis of chicken erythrocytes by an in vitro-established line of mouse peritoneal macrophages.
    Walker WS; Demus A
    J Immunol; 1975 Feb; 114(2 pt 2):765-9. PubMed ID: 1167563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of mice in immunotherapy of tumors with syngeneic antitumor serum plus lipopolysaccharide.
    Saito M; Yamazaki M; Mizuno D
    Gan; 1978 Jun; 69(3):331-7. PubMed ID: 352784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity mediated by soluble macrophage product(s).
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
    Carrel S; Delisle MC; Mach JP
    Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced susceptibility of glutaraldehyde-treated tumor cells to antibody-dependent macrophage-mediated cytolysis.
    Iwata-Dohi N; Esumi-Kurisu M; Ikenami M; Sadatsune K; Mizuno D; Yamazaki M
    Cancer Res; 1982 Aug; 42(8):3196-200. PubMed ID: 6807539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
    Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
    J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of syngeneic antitumor serum on mammary tumor in a syngeneic host.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):561-5. PubMed ID: 590680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of the effector cell in antibody-dependent, cell-mediated cytolysis (ADCC): the cytotoxic activity of murine tumor cells and peritoneal macrophages.
    Handwerger BS; Koren HS
    Clin Immunol Immunopathol; 1976 Mar; 5(2):272-81. PubMed ID: 1277588
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of macrophage-mediated tumor lysis by an animal lectin, Sarcophaga peregrina agglutinin.
    Nakajima H; Komano H; Esumi-Kurisu M; Abe S; Yamazaki M; Natori S; Mizuno D
    Gan; 1982 Aug; 73(4):627-32. PubMed ID: 7152198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of macrophage-mediated tumor lysis by the lectin wheat germ agglutinin.
    Kurisu M; Yamazaki M; Mizuno D
    Cancer Res; 1980 Oct; 40(10):3798-3803. PubMed ID: 7002291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.